Mediso proposes ultimatives Theranostik TheraMAX SPECT/CT for

HAMBURGGermany, 21. October 2024 /PRNewswire/ — Medio presented at the anniversary of the European Association of Nuclear Medicine (Europäische Vereinigung für Nuklearmedizin, EANM) a new AnyScan®TRIO SPECT/CT, TheraMAX*-Scanner for.

The new TheraMAX is specialized in the clinical treatment of theranostic images. Detection and collimators have been developed that provide imaging for soul-oriented radioactive therapies with radioisotopes, but do not emit Alpha and Beta radiation, but also high and ultra-high energy gamma photons that occur with them ¹⁷⁷Lu, ²¹²Pb, ¹³¹I, ²²⁵Ac and others.

The TheraMAX is equipped with three large detection towers (up to 5 times larger than 12-detector CZT systems), which provide sufficient axes for the patient (360°). The 15.9 mm thick NaI crystals have a higher empirical effect on the high temperature of photons, where a very dense sensor sensor (123 PMTs for detection headf) has a high degree of brightness, while a PET image quality is good for all NM Anwendungen erreicht rd.

Those in the overview of the double detector system with a 300% higher efficiency, ermöglicht Ganzkörper-SPECT/CT with 225-Ac in theranostic images, with this high-end system with ultra-fast quantitative Ganzkörper-SPECT/CT with ^99mTc and LEHR-HS-Collimators are visible. Darüber has developed the new Multi-Pinhole technology in combination with the Triple-NaI detection tower, a quantitative voltage for cardiology and neurology.

The integrated CT system contains three Leistungstufen: Low-Dose diagnostic scans, Ultra-Low-Dose-Protokoll with Abschwächungs- and Streukorrektur and the use of a “Zero-Dose” image with KI-gestütztem SyCT** (Synthetic CT) .

The best standard for the AnyScan® TRIO TheraMAX is the Universitätsklinikum Regensburg, Deutschland. Closer kürzlich inheritance Installation sagte Professor Dr. Dirk Hellwigder Leiter der Abteilung für Nuklearmedizin: „The new scanner would be our diagnostic and theranostische Arbeitsabläufe verbessern, was a better Patientenversorgung führt, and a new Möglichkeiten in the clinical Research eröffnet.”

“With the new TheraMAX technology, nuclear medical analyzes have been improved, with diagnostic tests from SPECT/CT specialists, who have dealt with PET/CT,” says Istvan Bagaméry, director of Mediso Ltd. “Der TheraMAX transforms the clinical routine through ultra-fast quantitative Ganzkörperscans.”

Read more